PMVP (STOCKS)
PMV Pharmaceuticals, Inc
$1.081700
-0.038300 (-3.42%)
Prev close: $1.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David H. Mack
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.47M
- Employees
- 47
- P/E (TTM)
- -0.68
- P/B (TTM)
- 0.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.40 | $-0.41 | +0.0106 | +2.58% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.39 | -0.0190 | -4.86% |
|
Mar 2025 (Q1)
|
$-0.34 | $-0.38 | +0.0419 | +10.97% |
|
Dec 2024 (Q4)
|
$-0.45 | $-0.39 | -0.0618 | -15.92% |
Financial Statements
| Assets | $133.84M |
| Current Assets | $132.45M |
| Cash | $129.25M |
| Other Current Assets | $3.20M |
| Noncurrent Assets | $1.40M |
| Fixed Assets | $255.00K |
| Other Non-current Assets | $1.14M |
| Liabilities | $12.85M |
| Current Liabilities | $12.30M |
| Accounts Payable | $3.40M |
| Other Current Liabilities | $8.91M |
| Noncurrent Liabilities | $541.00K |
| Equity | $121.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $121.00M |
| Liabilities And Equity | $133.84M |